FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2604270488> ?p ?o ?g. }

• W2604270488 endingPage "2355" @default.
• W2604270488 startingPage "2355" @default.
• W2604270488 abstract "To investigate the influence of interferon-free antivirus therapy on lipid profiles in chronic hepatitis C virus genotype 1b (HCV1b) infection.Interferon-free antiviral agents were used to treat 276 patients with chronic HCV1b infection, and changes in serum lipids of those who achieved sustained virologic response (SVR) were examined. The treatment regimen included 24 wk of daclatasvir plus asunaprevir (DCV + ASV) or 12 wk of sofosbuvir plus ledipasvir (SOF + LDV). SVR was achieved in 121 (85.8%) of 141 patients treated with DCV + ASV and 132 (97.8%) of 135 patients treated with SOF + LDV. In the two patient groups (DCV + ASV-SVR and SOF + LDV-SVR), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides were measured at baseline during treatment and at 4 and 12 wk after treatment. Then, longitudinal changes in lipid profiles were analyzed.Serum levels of TC, LDL-C, and HDL-C were significantly increased throughout the observation period in both the DCV + ASV-SVR and SOF + LDV-SVR groups. During antivirus treatment, the increases in TC and LDL-C were significantly greater in the SOF + LDV-SVR group than in the DCV + ASV-SVR group (P < 0.001). At 4 and 12 wk after the therapy, serum levels of TC and LDL-C were similar between the two groups and were significantly greater than those at baseline. Approximately 75%-80% of the increase in TC was derived from an increased LDL-C. In multiple regression analysis, the difference in therapy protocol (DCA + ASV or SOF + LDV) was an independent predictor that was significantly associated with the increase in TC and LDL-C at 4 wk of therapy.Serum cholesterol significantly increased during SOF + LDV treatment. After treatment, HCV elimination was associated with a similar increase in cholesterol regardless of the therapy protocol." @default.
• W2604270488 created "2017-04-14" @default.
• W2604270488 creator A5002653535 @default.
• W2604270488 creator A5010301471 @default.
• W2604270488 creator A5055227838 @default.
• W2604270488 creator A5060767540 @default.
• W2604270488 creator A5085648916 @default.
• W2604270488 date "2017-01-01" @default.
• W2604270488 modified "2023-10-16" @default.
• W2604270488 title "Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b" @default.
• W2604270488 cites W1551301313 @default.
• W2604270488 cites W1965212035 @default.
• W2604270488 cites W1969065116 @default.
• W2604270488 cites W1979907603 @default.
• W2604270488 cites W1986730863 @default.
• W2604270488 cites W2003982930 @default.
• W2604270488 cites W2015336471 @default.
• W2604270488 cites W2022396880 @default.
• W2604270488 cites W2028350152 @default.
• W2604270488 cites W2033664904 @default.
• W2604270488 cites W204086469 @default.
• W2604270488 cites W2043976325 @default.
• W2604270488 cites W2047028523 @default.
• W2604270488 cites W2057967679 @default.
• W2604270488 cites W2085427068 @default.
• W2604270488 cites W2088337621 @default.
• W2604270488 cites W2093010954 @default.
• W2604270488 cites W2101598010 @default.
• W2604270488 cites W2105572022 @default.
• W2604270488 cites W2129324137 @default.
• W2604270488 cites W2142660384 @default.
• W2604270488 cites W2142866037 @default.
• W2604270488 cites W2147822795 @default.
• W2604270488 cites W2166962970 @default.
• W2604270488 cites W2286811631 @default.
• W2604270488 cites W2398561793 @default.
• W2604270488 cites W2403935724 @default.
• W2604270488 cites W2514499533 @default.
• W2604270488 cites W2524545167 @default.
• W2604270488 cites W2565050364 @default.
• W2604270488 cites W2893056655 @default.
• W2604270488 cites W4211105405 @default.
• W2604270488 cites W4246639567 @default.
• W2604270488 doi "https://doi.org/10.3748/wjg.v23.i13.2355" @default.
• W2604270488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5385402" @default.
• W2604270488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28428715" @default.
• W2604270488 hasPublicationYear "2017" @default.
• W2604270488 type Work @default.
• W2604270488 sameAs 2604270488 @default.
• W2604270488 citedByCount "35" @default.
• W2604270488 countsByYear W26042704882017 @default.
• W2604270488 countsByYear W26042704882018 @default.
• W2604270488 countsByYear W26042704882019 @default.
• W2604270488 countsByYear W26042704882020 @default.
• W2604270488 countsByYear W26042704882021 @default.
• W2604270488 countsByYear W26042704882022 @default.
• W2604270488 countsByYear W26042704882023 @default.
• W2604270488 crossrefType "journal-article" @default.
• W2604270488 hasAuthorship W2604270488A5002653535 @default.
• W2604270488 hasAuthorship W2604270488A5010301471 @default.
• W2604270488 hasAuthorship W2604270488A5055227838 @default.
• W2604270488 hasAuthorship W2604270488A5060767540 @default.
• W2604270488 hasAuthorship W2604270488A5085648916 @default.
• W2604270488 hasBestOaLocation W26042704881 @default.
• W2604270488 hasConcept C126322002 @default.
• W2604270488 hasConcept C203014093 @default.
• W2604270488 hasConcept C2522874641 @default.
• W2604270488 hasConcept C2776178377 @default.
• W2604270488 hasConcept C2776979040 @default.
• W2604270488 hasConcept C2778096610 @default.
• W2604270488 hasConcept C2778163477 @default.
• W2604270488 hasConcept C2778390639 @default.
• W2604270488 hasConcept C2780040827 @default.
• W2604270488 hasConcept C2780072125 @default.
• W2604270488 hasConcept C2781413609 @default.
• W2604270488 hasConcept C3020491458 @default.
• W2604270488 hasConcept C511355011 @default.
• W2604270488 hasConcept C71924100 @default.
• W2604270488 hasConcept C90924648 @default.
• W2604270488 hasConceptScore W2604270488C126322002 @default.
• W2604270488 hasConceptScore W2604270488C203014093 @default.
• W2604270488 hasConceptScore W2604270488C2522874641 @default.
• W2604270488 hasConceptScore W2604270488C2776178377 @default.
• W2604270488 hasConceptScore W2604270488C2776979040 @default.
• W2604270488 hasConceptScore W2604270488C2778096610 @default.
• W2604270488 hasConceptScore W2604270488C2778163477 @default.
• W2604270488 hasConceptScore W2604270488C2778390639 @default.
• W2604270488 hasConceptScore W2604270488C2780040827 @default.
• W2604270488 hasConceptScore W2604270488C2780072125 @default.
• W2604270488 hasConceptScore W2604270488C2781413609 @default.
• W2604270488 hasConceptScore W2604270488C3020491458 @default.
• W2604270488 hasConceptScore W2604270488C511355011 @default.
• W2604270488 hasConceptScore W2604270488C71924100 @default.
• W2604270488 hasConceptScore W2604270488C90924648 @default.
• W2604270488 hasIssue "13" @default.
• W2604270488 hasLocation W26042704881 @default.
• W2604270488 hasLocation W26042704882 @default.
• W2604270488 hasLocation W26042704883 @default.

• next